Cargando…
Endogenous melatonin in critically ill patients
Autores principales: | Salice, VS, Galluccio, IG, Salihovic, BS, Piva, IP, Marazzo, FM, Villa, CV, Taverna, MT, Umbrello, MU, Mistraletti, GM, Iapichino, GI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643088/ http://dx.doi.org/10.1186/cc12388 |
Ejemplares similares
-
Oral melatonin in high-risk critically ill patients: quality of sedative effect
por: Sabbatini, G, et al.
Publicado: (2012) -
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
por: Mistraletti, Giovanni, et al.
Publicado: (2017) -
Tolvaptan for hyponatremia with preserved sodium pool in critically ill patients
por: Umbrello, Michele, et al.
Publicado: (2016) -
Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation: a pilot clinical study
por: Umbrello, Michele, et al.
Publicado: (2015) -
Pharmacokinetics of orally administered melatonin in critically ill patients
por: Moroni, B, et al.
Publicado: (2010)